• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较计算疫苗效力置信区间的方法。

Comparing methods for calculating confidence intervals for vaccine efficacy.

作者信息

Ewell M

机构信息

EMMES Corporation, Potomac, Maryland 20854, USA.

出版信息

Stat Med. 1996;15(21-22):2379-92. doi: 10.1002/(SICI)1097-0258(19961115)15:21<2379::AID-SIM457>3.0.CO;2-L.

DOI:10.1002/(SICI)1097-0258(19961115)15:21<2379::AID-SIM457>3.0.CO;2-L
PMID:8931208
Abstract

A method is introduced for computing a Bayesian 95 per cent posterior probability region for vaccine efficacy. This method assumes independent vague gamma prior distributions for the incidence rates on each arm of the trial, and a Poisson likelihood for the counts of incident cases of infection. The approach is similar in spirit to the Bayesian analysis of the binomial risk ratio described by Aitchison and Bacon-Shone. However, the focus of our interest is not on incorporating prior information into the design of trials for efficacy, but rather on evaluating whether or not the Bayesian approach with vague prior information produces comparable results to a frequentist approach. A review of methods for constructing exact and large sample intervals for vaccine efficacy is provided as a framework for comparison. The confidence interval methods are assessed by comparing the size and power of tests of vaccine efficacy in proposed intermediate sized randomized double blinded placebo controlled trials.

摘要

本文介绍了一种计算疫苗效力的贝叶斯95%后验概率区域的方法。该方法假定试验各臂上的发病率服从独立的模糊伽马先验分布,且感染病例数服从泊松似然分布。这种方法在本质上与艾奇逊和培根-肖恩所描述的二项风险比的贝叶斯分析相似。然而,我们感兴趣的重点不是将先验信息纳入效力试验的设计中,而是评估具有模糊先验信息的贝叶斯方法是否能产生与频率论方法可比的结果。作为比较框架,本文提供了关于构建疫苗效力精确和大样本区间方法的综述。通过比较拟议的中等规模随机双盲安慰剂对照试验中疫苗效力检验的大小和功效,对置信区间方法进行了评估。

相似文献

1
Comparing methods for calculating confidence intervals for vaccine efficacy.比较计算疫苗效力置信区间的方法。
Stat Med. 1996;15(21-22):2379-92. doi: 10.1002/(SICI)1097-0258(19961115)15:21<2379::AID-SIM457>3.0.CO;2-L.
2
Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials.贝叶斯统计推断增强了对当代随机对照试验的解读。
J Clin Epidemiol. 2009 Jan;62(1):13-21.e5. doi: 10.1016/j.jclinepi.2008.07.006. Epub 2008 Oct 23.
3
A control-conditional test for assessing HIV vaccine efficacy in small sample preclinical studies.一种用于在小样本临床前研究中评估HIV疫苗效力的对照条件测试。
Stat Med. 1996;15(21-22):2371-8; discussion 2405-12. doi: 10.1002/(SICI)1097-0258(19961115)15:21<2371::AID-SIM456>3.0.CO;2-B.
4
Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.基于二次损失函数的贝叶斯决策理论组序贯临床试验设计:频率学派评估
Clin Trials. 2007;4(1):5-14. doi: 10.1177/1740774506075764.
5
Frequentist performance of Bayesian confidence intervals for comparing proportions in 2 x 2 contingency tables.2×2列联表中用于比较比例的贝叶斯置信区间的频率主义性能
Biometrics. 2005 Jun;61(2):515-23. doi: 10.1111/j.1541-0420.2005.031228.x.
6
Confidence intervals for a ratio of two independent binomial proportions.两个独立二项比例之比的置信区间。
Stat Med. 2008 Nov 20;27(26):5497-508. doi: 10.1002/sim.3376.
7
Bayesian methods of analysis for cluster randomized trials with count outcome data.基于计数结局的整群随机试验的贝叶斯分析方法。
Stat Med. 2010 Jan 30;29(2):199-209. doi: 10.1002/sim.3747.
8
Bayesian evaluation of group sequential clinical trial designs.成组序贯临床试验设计的贝叶斯评估。
Stat Med. 2007 Mar 30;26(7):1431-49. doi: 10.1002/sim.2640.
9
Bayesian approach to noninferiority trials for proportions.比例非劣效性试验的贝叶斯方法。
J Biopharm Stat. 2011 Sep;21(5):902-19. doi: 10.1080/10543406.2011.589646.
10
Constructing intervals for the intracluster correlation coefficient using Bayesian modelling, and application in cluster randomized trials.使用贝叶斯模型构建组内相关系数的区间,并应用于整群随机试验。
Stat Med. 2006 May 15;25(9):1443-56. doi: 10.1002/sim.2304.

引用本文的文献

1
Adopting the estimand framework in prophylactic vaccine trials.在预防性疫苗试验中采用估计量框架。
Vaccine. 2025 Sep 3;64:127645. doi: 10.1016/j.vaccine.2025.127645.
2
Head-to-head comparison of two human papillomavirus vaccines for efficacy against cervical intraepithelial neoplasia grade 3 and adenocarcinoma -population-based follow-up of two cluster-randomized trials.两种人乳头瘤病毒疫苗在预防宫颈上皮内瘤变 3 级和腺癌方面的疗效头对头比较-基于人群的两项集群随机试验随访。
Front Cell Infect Microbiol. 2024 Sep 9;14:1437704. doi: 10.3389/fcimb.2024.1437704. eCollection 2024.
3
On Some Modeling Issues in Estimating Vaccine Efficacy.
关于估计疫苗效力中的一些建模问题。
Pharm Stat. 2025 Jan-Feb;24(1):e2440. doi: 10.1002/pst.2440. Epub 2024 Sep 9.
4
Confidence interval estimation for vaccine efficacy against COVID-19.针对新冠病毒病疫苗效力的置信区间估计。
Front Public Health. 2022 Aug 12;10:848120. doi: 10.3389/fpubh.2022.848120. eCollection 2022.
5
Human papillomavirus vaccine efficacy against invasive, HPV-positive cancers: population-based follow-up of a cluster-randomised trial.人乳头瘤病毒疫苗对侵袭性 HPV 阳性癌症的功效:基于人群的集群随机试验随访。
BMJ Open. 2021 Dec 30;11(12):e050669. doi: 10.1136/bmjopen-2021-050669.
6
An agent-based model of dengue virus transmission shows how uncertainty about breakthrough infections influences vaccination impact projections.基于代理的登革热病毒传播模型展示了对突破性感染的不确定性如何影响疫苗接种效果预测。
PLoS Comput Biol. 2019 Mar 20;15(3):e1006710. doi: 10.1371/journal.pcbi.1006710. eCollection 2019 Mar.
7
Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of .人乳头瘤病毒疫苗针对最严格的宫颈肿瘤终点(基于登记处的随访)的十年随访
BMJ Open. 2017 Aug 18;7(8):e015867. doi: 10.1136/bmjopen-2017-015867.
8
Dramatic decline of serogroup C meningococcal disease incidence in Catalonia (Spain) 24 months after a mass vaccination programme of children and young people.在对儿童和青少年实施大规模疫苗接种计划24个月后,西班牙加泰罗尼亚地区C群脑膜炎球菌病发病率急剧下降。
J Epidemiol Community Health. 2001 Apr;55(4):283-7. doi: 10.1136/jech.55.4.283.